Intracellular concentration and transporters in imatinib resistance of gastrointestinal stromal tumor-Reference-Cited by-同舟云学术

Intracellular concentration and transporters in imatinib resistance of gastrointestinal stromal tumor

Published:2019-02-01 Issue:2 Volume:54 Page:220-226
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Zhang Qiang¹²,Li Zheng¹²,Xu Kangjing¹²,Qian Yi³,Chen Ming¹²,Sun Luning³,Song Shanshan⁴,Huang Xiaoxu¹⁵,He Zhongyuan¹²,Li Fengyuan¹²,Zhang Diancai¹²,Yang Li¹²,Wang Yongqing³,Xu Hao¹²,Xu Zekuan¹²

Affiliation:

1. Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China;

2. Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, China;

3. Research Division of Clinical Pharmacology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China;

4. Department of Pathology, Xuzhou Medical University Affiliated Hospital of Lianyungang, Lianyungang, China;

5. Department of Gastrointestinal Surgery, The First Affiliated Yijishan Hospital of Wannan Medical College, Anhui, Wuhu, China

Funder

Natural Science Foundation of Province

Jiangsu Key Medical Discipline

the Priority Academic Program Development of Jiangsu Higher Education Institutions

Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative, Nanjing Medical University

National Natural Science Foundation of China

Construction Program of Jiangsu Provincial Clinical Research Center Support System

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2019.1577488

Reference24 articles.

1. Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis

2. Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

3. PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

4. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST)

5. GI Stromal Tumors: 15 Years of Lessons From a Rare Cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytohemagglutinin from Phaseolus vulgaris enhances the lung cancer cell chemotherapy sensitivity by changing cell membrane permeability;Journal of Natural Medicines;2024-01-24

2. Pretreatment and analysis techniques development of TKIs in biological samples for pharmacokinetic studies and therapeutic drug monitoring;Journal of Pharmaceutical Analysis;2023-11

3. Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?;Cancers;2023-05-23

4. Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors;Frontiers in Oncology;2022-09-06

5. SPK1/S1P axis confers gastrointestinal stromal tumors (GISTs) resistance of imatinib;Gastric Cancer;2022-08-24